M42 and 10XREVIV Launch Clinical Study on Precision Nutrition for GLP-1 Therapy Patients
Abu Dhabi:M42’s Insights Research Organisation and Solutions (IROS) and 10XREVIV have announced a clinical study to assess the impact of precision nutrition on patients receiving GLP-1 therapies. The study aims to support the nutritional health and we…